Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Mysthera Therapeutics
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices